Search hospitals > Florida > Clearwater

Clearwater Cardiovascular Consultants

Claim this profile
Clearwater, Florida 33756
Global Leader in Cardiovascular Disease
Global Leader in Coronary Artery Disease
Conducts research for Heart Failure
Conducts research for Atherosclerosis
Conducts research for Coronary Syndrome
41 reported clinical trials
5 medical researchers
Photo of Clearwater Cardiovascular Consultants in ClearwaterPhoto of Clearwater Cardiovascular Consultants in ClearwaterPhoto of Clearwater Cardiovascular Consultants in Clearwater

Summary

Clearwater Cardiovascular Consultants is a medical facility located in Clearwater, Florida. This center is recognized for care of Cardiovascular Disease, Coronary Artery Disease, Heart Failure, Atherosclerosis, Coronary Syndrome and other specialties. Clearwater Cardiovascular Consultants is involved with conducting 41 clinical trials across 79 conditions. There are 5 research doctors associated with this hospital, such as Syed Masood Gilani, Navas, Douglas Spriggs, MD, and Donald Kikta, MD.

Top PIs

Clinical Trials running at Clearwater Cardiovascular Consultants

Cardiovascular Disease
High Blood Pressure
Heart Failure
Coronary Artery Disease
Acute Kidney Injury
Peripheral Arterial Disease
Hypercholesterolemia
Percutaneous Coronary Intervention
Angioplasty
Coronary Artery Stenosis
Image of trial facility.

Inclisiran

for Angioplasty

V-INTERVENTION will evaluate the effectiveness of inclisiran in preventing major cardiovascular and limb events in patients receiving percutaneous coronary or peripheral arterial revascularization. Inclisiran is a subcutaneous, twice-yearly injection that is FDA-approved as an adjunct with statin therapy and on the market to lower LDL-C in high-risk populations.
Recruiting2 awards Phase 41 criteria
Image of trial facility.

Sirolimus-Coated Balloon

for Coronary Artery Disease

This is a multicenter, randomized, single-blind pivotal study to evaluate the safety and efficacy of the MagicTouchTM Drug coated balloon in treatment of small vessels in patients with coronary artery disease. The objective is to establish the safety and efficacy of the Magic TouchTM Drug coated balloon in treatment of small vessels (≤2.75 mm). A total of 1605 subjects will be enrolled in a maximum of 50 study sites located in North America. Additional sites located in Europe and South America may also participate in the study, with non-US sites contributing a maximum of \~50% of enrollees.
Recruiting1 award N/A6 criteria
Image of trial facility.

Olpasiran

for Cardiovascular Disease

The primary objective is to evaluate the effect of olpasiran, compared to placebo, on the risk for coronary heart disease death (CHD death), myocardial infarction, or urgent coronary revascularization in participants at risk for a first major cardiovascular event with elevated lipoprotein(a) (Lp\[a\]).
Recruiting1 award Phase 32 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Clearwater Cardiovascular Consultants?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security